Atrial Fibrillation, Chronic Pain, Diabetes Mellitus, Type 2
Conditions
Brief summary
Primary objective shared by the 3 registries : Describe the different pharmacotherapeutic management in patients : * DB (Diabetes): with type 2 diabetes, treated with oral and / or injectable antidiabetics * CP (Chronic Pain): with any disease leading to chronic pain (lasting for more than 3 months) * AF (Atrial Fibrillation): with ongoing AF or AF diagnosed within 12 months before enrollment Secondary objectives shared by the 3 observatories: * Describe the occurrence of clinical events, hospitalizations and death, according to the different medical care conditions, and analyze their predicting factors * Estimate the resources consumption according to the medical and non medical management of these patients, * Analyze the impact of some factors (patient's cognitive status, autonomy, renal function ...) on the current practice Secondary objectives specific shared by DB and AF registries : \- Analyze the geriatric pharmaco-genetic aspects Specific secondary objectives for each observatory : * DB : Describe HbA1c level, percentage of responders and body weight evolution according to the different medical care conditions * CP : Evaluate pain consequences on Daily Living Activities and patient autonomy
Interventions
None listed
Sponsors
Sanofi
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No
Inclusion criteria
specific for each observatory : * DB : Established type 2 diabetes treated with oral and / or injectable antidiabetics * CP : Pain lasting for over 3 months, requiring therapeutic care * FA : Ongoing Atrial fibrillation or AF diagnosed within the 12 months before enrollment and documented by ECG or Holter ECG, whatever the rhythm at inclusion
Exclusion criteria
shared by the 3 observatories: * Living in accommodation facility for dependent patients * Patient with non cardiovascular progressively unstable disease * Patient already enrolled in a clinical trial * Patient unlikely to complete the study
Countries
France
Outcome results
None listed